In the present study, our results demonstrated that miR-106b activated the MAPK signaling pathway, while NR2F2-AS1 and PLEKHO2 inhibited the MAPK signaling pathway in CRC. This evidence concerns the gene NR2F2 and colorectal carcinoma.